Bayer | BAYN - Operating Expenses


Bayer reported EUR9.88B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Air Liquide EUR 10.93B 561.2M Jun/2026
Akzo Nobel EUR 2.34B 206M Jun/2026
Alcon AG USD 2.41B 4M Mar/2026
Amarin USD 51.48M 113K Dec/2025
Arkema EUR 2.24B 139.2M Jun/2026
AstraZeneca USD 12.22B 4.04B Jun/2026
BASF EUR 15.77B 1.16B Jun/2026
Bayer EUR 9.88B 452M Mar/2026
Beiersdorf EUR 4.16B 212M Dec/2025
Corteva USD 4.43B 678.08M Jun/2026
Covestro EUR 3.24B 5.46B Dec/2025
Essilor EUR 12.52B 568M Jun/2026
Fresenius EUR 5.23B 9M Jun/2026
Fresenius Medical Care EUR 4.34B 63M Mar/2026
Genmab DKK 798M 235M Dec/2025
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 5.8B 468M Jun/2026
GRIFOLS EUR 1.55B 94M Jun/2026
Henkel EUR 8.67B 122M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Johnson Matthey GBP 7.02B 1.81B Jun/2026
Linde USD 6.4B 112M Mar/2026
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.09B 687M Mar/2026
Novartis USD 10.2B 912M Jun/2026
Nutrien USD 5.67B 1.03B Mar/2026
Philips EUR 3.75B 147M Jun/2026
PPG Industries USD 3.86B 4.24B Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Sanofi EUR 9.92B 607M Jun/2026
SAP EUR 7.24B 11.46B Jun/2026
Solvay EUR 1.07B 44M Jun/2026
UCB EUR 2.96B 196M Dec/2025
Umicore EUR 27.12B 17.15B Jun/2026
Vinci EUR 32.03B 2.09B Jun/2026